Products | Oncology Diagnostics | September 18, 2015

EMI-137

EMI-137

Related Content

Raidium Debuts New AI-Native PACS Viewer
News | PACS
Raidium Debuts New AI-Native PACS Viewer

Dec. 1, 2025 — At RSNA 2025, Raidium is introducing its new AI-native PACS Viewer powered by Curia, the first Foundation ...

Time December 01, 2025
arrow
Researchers Develop Imaging Probe That Helps Track, Possibly Treat, Prostate Cancer 
News | Prostate Cancer
Researchers Develop Imaging Probe That Helps Track, Possibly Treat, Prostate Cancer 

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
Sponsored Content | Videos | Radiology Business
VIDEO: Talking Trends with Bayer Radiology — Navigating Market Disruptions to Your CT Suite

Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...

Time October 09, 2025
arrow
Study: Contrast-Enhanced Ultrasound is Safe, Saves lives
News | Ultrasound Imaging
Study: Contrast-Enhanced Ultrasound is Safe, Saves lives

May 14, 2025 — A comprehensive new study based on nationwide claims data from more than 11 million patients shows that ...

Time May 14, 2025
arrow
Bracco and Blue Earth Diagnostics has announced the appointment of Marco Campione as new CEO, effective immediately. Campione succeeds David Gauden, D. Phil., who now assumes the role of CEO of Bracco subsidiary Blue Earth Therapeutics.
News | Radiology Business
Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer

July 9, 2024 — Bracco and Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time July 09, 2024
arrow
Penn Medicine will have a strong presence at the upcoming American Society of Clinical Oncology (ASCO) 2024 Annual Meeting.
News | Clinical Trials
Penn Medicine to Present Multiple Clinical Trial Results at 2024 ASCO Annual Meeting

May 30, 2024 — Researchers from Penn Medicine’s Abramson Cancer Center (ACC) and the Perelman School of Medicine at the ...

Time May 29, 2024
arrow
Swedish biotech company Ascelia Pharma has announced its liver imaging drug candidate, Orviglance, significantly improved visualization of focal liver lesions, having successfully met the primary endpoint in the pivotal Phase 3 study, SPARKLE. CEO Magnus Corftizen shown here, offered an update on the first-in-class contrast agent for use in liver MRI in patients with severely impaired kidney function which has been granted FDA Orphan Drug Designation.
News | Contrast Media
Ascelia Pharma Meets Primary Endpoint in Phase 3 Study of Orviglance Liver Imaging Contrast Agent Drug Candidate

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
LUMISIGHT and Lumicell Direct Visualization System (DVS) offer 84% diagnostic accuracy in detecting residual cancer, in real-time, that may have been otherwise missed during lumpectomy surgery, while sparing some from second surgeries
News | FDA
Lumicell’s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
Ga-68 has a very short half-life, which presents logistical challenges in distribution
News | Radiopharmaceuticals and Tracers
RLS Radiopharmacies Partners with Eckert and Ziegler to Expand Production of Gallium-68-Based Radiopharmaceuticals

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
With the addition of MIM Software, GE HealthCare aims to provide clinicians and healthcare systems with increasingly integrated and automated solutions
News | Radiology Business
GE HealthCare Closes MIM Software Acquisition

April 2, 2024 — Less than three months after signing an agreement to acquire MIM Software Inc., GE HealthCare ...

Time April 02, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now